Compounds > 3-hydroxyephedrine
Page last updated: 2024-08-22

3-hydroxyephedrine and fluorodeoxyglucose f18

3-hydroxyephedrine has been researched along with fluorodeoxyglucose f18 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baro, ME; Castle, VP; Dole, MG; Hutchinson, RJ; Mitchell, DS; Rawwas, JB; Shulkin, BL; Sisson, JC; Ungar, DR; Wieland, DM1
Byrd, DR; Kinahan, PE; Krohn, KA; Link, JM; Mankoff, DA; Mann, GN; Pham, P; Pickett, CA1
Karges, W; Mottaghy, FM; Van Binnebeek, S1
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G1
Giovanella, L; July, M; Santhanam, P; Treglia, G1

Reviews

2 review(s) available for 3-hydroxyephedrine and fluorodeoxyglucose f18

ArticleYear
PET/CT imaging in neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed

2013
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
    Clinical physiology and functional imaging, 2018, Volume: 38, Issue:1

    Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin

2018

Trials

1 trial(s) available for 3-hydroxyephedrine and fluorodeoxyglucose f18

ArticleYear
[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
    Annals of surgical oncology, 2006, Volume: 13, Issue:2

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Ephedrine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome

2006

Other Studies

2 other study(ies) available for 3-hydroxyephedrine and fluorodeoxyglucose f18

ArticleYear
PET hydroxyephedrine imaging of neuroblastoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Carbon Radioisotopes; Child; Child, Preschool; Contrast Media; Deoxyglucose; Ephedrine; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Time Factors; Tomography, Emission-Computed

1996
Functional imaging of neuroendocrine tumors.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727

    Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin

2011